source
- J&J EVP John Reed Discusses R&D Model, Oncology Deals and Pipeline Growth PotentialJohn Reed, executive vice president of Innovative Medicine at Johnson & Johnson, brings more than a decade of experience overseeing drug pipelines at three of the world’s largest pharmaceutical com…
- Over 200 biopharma investors urge EU governments to strengthen Europe's life-science sectorMore than 200 biopharma investors and companies have signed an open letter addressed to EU member states, calling for action to improve Europe's life‑science sector. The signatories argue that Eur…